D-aspartate

DIETARY_SUPPLEMENT2 trials

Sponsors

Neuromed IRCCS, Merck KGaA, Darmstadt, Germany

Conditions

Brain InjuriesMultiple Sclerosis, Relapsing-Remitting

Early Phase 1

D-aspartate and Therapeutic Exercise

Neuromed IRCCSBrain Injuries

Start: 2017-11-22End: 2022-12-01Target: 100Updated: 2019-03-15

Phase 2

A Pilot Study in Participants With Relapsing Remitting Multiple Sclerosis (RR-MS)

TerminatedNCT03387046

Merck KGaA, Darmstadt, GermanyMultiple Sclerosis, Relapsing-Remitting

Start: 2018-03-26End: 2019-01-11Updated: 2020-02-10